Why choose us
- Expertise BioVirtus can execute large long-confinement studies with up to 45 subjects.
- Effectiveness Thanks to a large database of subjects BioVirtus guarantees swift and effective recruitment, screening and enrolment.
- Easiness We have the ability to quickly enrol patients with various diseases.
Study Type & Design
The BioVirtus team has broad experience in conducting even most complex protocols with most demanding design:
- single and multiple dose
- fast, fed and steady state
- open-label
- single- and double-blind
- parallel
- 2, 3, 4-way cross-over
- ascending dose
- pilot and pivotal
- long confinement
BioVirtus Research Site specializes in the following types of clinical studies:
- first-in-man
- proof-of-concept
- bioavailability and drug metabolism
- bioequivalence
- therapeutic equivalence
- pharmacokinetics (PK)
- pharmacodynamics (PD)
- genotyping
- drug interaction
- dose escalation
- food effect
- biosimilars
- new forms of products
- safety profile and product tolerance
- medical experiments
- special populations
- healthy subjects.